Verona Pharma PLC ADR (VRNA) — Capital Reinvestment Ratio

Latest as of September 2021: 0.00x

Verona Pharma PLC ADR (VRNA) has a Capital Reinvestment Ratio of 0.00x as of September 2021, meaning it reinvests 0% of its operating cash flow ($22.82 Million) in capital expenditures ($11.00K). See VRNA equity financing ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

$22.82 Million

USD

Capital Expenditures

$11.00K

USD

Data as of

Sep 2021

Most recent filing

Annual Capital Reinvestment Ratio for Verona Pharma PLC ADR (None–None)

Year-by-year Capital Reinvestment Ratio for Verona Pharma PLC ADR from None to None. For live market cap and broader valuation context, see VRNA stock market capitalisation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow